Page 7 - Primary Biliary Cholangitis News Today : Breaking News, Live Updates & Top Stories | Vimarsana

GENFIT Announces Revenues and Cash Position as of December 31, 2023

GENFIT Announces Revenues and Cash Position as of December 31, 2023
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

France generalUnited statesUnited kingdomStephanie boyerInternational financial reporting standardsEuropean medicines agencyTransition services agreementUncertainties of the companyPartb transition services agreementUpcoming financial communicationsDrug administrationExchange commissionNew drug applicationMarketing authorization applicationPrimary biliary cholangitisAcute on chronic liver failure

GENFIT Announces Revenues and Cash Position as of December 31, 2023

GENFIT Announces Revenues and Cash Position as of December 31, 2023
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United kingdomUnited statesFrance generalStephanie boyerUncertainties of the companyPartb transition services agreementDrug administrationExchange commissionTransition services agreementEuropean medicines agencyInternational financial reporting standardsUpcoming financial communicationsCash positionNew drug applicationMarketing authorization applicationPrimary biliary cholangitis

GENFIT Announces Revenues and Cash Position as of December 31, 2023

GENFIT Announces Revenues and Cash Position as of December 31, 2023
benzinga.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from benzinga.com Daily Mail and Mail on Sunday newspapers.

United statesFrance generalUnited kingdomStephanie boyerEuropean medicines agencyUncertainties of the companyTransition services agreementDrug administrationInternational financial reporting standardsUpcoming financial communicationsExchange commissionPartb transition services agreementNew drug applicationMarketing authorization applicationPrimary biliary cholangitisAcute on chronic liver failure

Study shows seladelpar beneficial for patients with primary biliary cholangitis

Study shows seladelpar beneficial for patients with primary biliary cholangitis
medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.

Gideonm hirschfieldBernd schnablDavidn assisUniversity health networkNew england journalPrimary biliary cholangitisAdvancing second line treatment

Zydus aims to launch first new drug in US by early 2026

Zydus will enter a competitive field, with an FDA decision on CymaBay s PBC drug due in August. Gilead Sciences announced its acquisition of CymaBay for $4.3 billion earlier in February. Saroglitazar, currently in a mid-to-late-stage trial for PBC, is also being tested for Metabolic Dysfunction-Associated Steatohepatitis (MASH), a type of fatty liver disease."

United statesZydus lifesciencesSun pharma ciplaSharvil patelNovo nordiskGilead sciencesManaging director sharvil patelPrimary biliary cholangitisMetabolic dysfunction associated steatohepatitisLiver diseaseEarly 2026New drugSun pharma